United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market (2025-2031) Outlook | Analysis, Size, Growth, Industry, Trends, Revenue, Value, Forecast, Share & Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle

3.4 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces

3.5 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F

3.6 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing demand for personalized medicines and advanced therapies

4.2.2 Increasing research and development activities in cell and gene therapy

4.2.3 Favorable regulatory environment supporting cell and gene therapy manufacturing

4.3 Market Restraints

4.3.1 High cost associated with cell and gene therapy manufacturing

4.3.2 Limited skilled workforce in specialized manufacturing processes

4.3.3 Challenges in scaling up production to meet market demand

6.1 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market, By Vector

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2018 - 2027F

6.1.3 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2018 - 2027F

6.1.4 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2018 - 2027F

6.2 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2018 - 2027F

6.2.3 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2018 - 2027F

6.2.4 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2018 - 2027F

6.2.5 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2018 - 2027F

7.1 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries

7.2 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries

8.1 Percentage increase in the number of clinical trials utilizing cell and gene therapies in the UK

8.2 Adoption rate of automated manufacturing technologies in cell and gene therapy production facilities

8.3 Number of partnerships and collaborations between UK contract manufacturers and biopharmaceutical companies in the cell and gene therapy space.

9.1 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F

9.2 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2021

10.2 United Kingdom (UK) Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters